Approximately 25% of pediatric B-cell precursor ALL (BCP-ALL) patients carry the t(12;21)(p13;q22) translocation, which fuses the N-terminal part of the ETS variant 6 (ETV6) with virtually the entire Runt-related transcription factor 1 (RUNX1). This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.